newsfilter
← Latest News
PR Newswire·

Evofem Biosciences Announces Financial Results for the First Quarter of 2023

-- Increased net product revenue 37% in the first quarter of 2023 vs. prior year quarter -- -- Reduced operating expenses 72% -- -- Decreased loss from operations by 88% -- -- Reaffirms path to positive EBITDA -- SAN